MENU
Go to the list of all blogs
Anna G's Avatar
published in Blogs
Jul 01, 2022

Beyond Air (XAIR, $6.25) reported wider-than-expected loss per share

Beyond Air posted a loss of ($0.73) a share for the quarter, missing analysts’ consensus estimates of ($0.24). In the year-ago quarter, the company posted ($0.24) EPS.

Analysts expect Beyond Air earnings per share of -1.18 for  for the current year.

Beyond Air shares got a price target raise by LADENBURG THALM/SH SH from $17.00 to $23.00 in a research report sent to investors on Wednesday, (according to The Fly report). They have a buy rating on the stock at present.

Related Ticker: XAIR

XAIR's RSI Oscillator sits in oversold zone for 1 day

It is expected that a price bounce should occur soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Moving Average Convergence Divergence (MACD) for XAIR just turned positive on November 26, 2025. Looking at past instances where XAIR's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

XAIR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XAIR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for XAIR entered a downward trend on December 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.717) is normal, around the industry mean (63.123). P/E Ratio (0.000) is within average values for comparable stocks, (37.002). XAIR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.660). XAIR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (0.996) is also within normal values, averaging (34.591).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. XAIR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XAIR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Boston Scientific Corp (NYSE:BSX), Medtronic plc (NYSE:MDT), Edwards Lifesciences Corp (NYSE:EW).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 5.77B. The market cap for tickers in the group ranges from 1.86K to 222.59B. ABT holds the highest valuation in this group at 222.59B. The lowest valued company is CSAY at 1.86K.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was -1%. For the same Industry, the average monthly price growth was 0%, and the average quarterly price growth was 8%. FZMD experienced the highest price growth at 205%, while FOFA experienced the biggest fall at -52%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was -38%. For the same stocks of the Industry, the average monthly volume growth was -40% and the average quarterly volume growth was 3%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 74
Price Growth Rating: 62
SMR Rating: 85
Profit Risk Rating: 93
Seasonality Score: 23 (-100 ... +100)
View a ticker or compare two or three
XAIR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

a medical device company, which engages in the development of nitric oxide (NO) generator and delivery system.

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
900 Stewart Avenue
Phone
+1 516 665-8200
Employees
98
Web
https://www.beyondair.net
Interact to see
Advertisement
A powerful recession signal is flashing red: the Leading/Lagging Ratio has plunged to levels not seen since 2008. As markets grow turbulent, smart investors are turning to Tickeron’s AI trading agents to spot opportunities and stay ahead of the downturn.
#trading#artificial_intelligence
AI trading bots are no longer just experimental—they’re outperforming traditional strategies. Discover how bots trading ITA, TSM, META, and others achieved over 40% annual returns and what this means for the future of investing.
FingerMotion (FNGR) is making waves in 2025 with a 52% stock surge, strategic AI expansion into Indonesia, and strong retail momentum. Learn how traders are using correlation analysis, inverse ETFs, and Tickeron’s AI tools to navigate FNGR’s dynamic moves.
#artificial_intelligence#trading
Ferrari (RACE) is accelerating in 2025 with a 25% YTD gain, strong earnings, and bullish momentum fueled by innovation and Lewis Hamilton’s F1 move. Discover how Tickeron’s AI tools help traders capitalize on this luxury stock’s high-performance potential.
Intel’s stock is down 64%, but a bold turnaround under new CEO Lip-Bu Tan and the upcoming 18A chip rollout could spark a rebound. This article explores Intel’s financials, strategic shifts, and how AI tools from Tickeron help traders navigate the volatility.
#artificial_intelligence
Dogecoin (DOGE) fell 12.78% in five days, rattled by whale activity, Musk headlines, and ETF rumors. Is a breakout coming—or more downside? Explore key trends, technical levels, and how Tickeron’s AI bots help traders navigate DOGE’s next move.
The week of June 2-6, 2025, saw financial markets demonstrate resilience amid U.S.-China trade tensions and key economic data releases.
Tesla, Inc. (TSLA), a global leader in electric vehicles (EVs) and artificial intelligence (AI)-driven technologies, has been a focal point for investors in 2025.
#artificial_intelligence#trading
As artificial intelligence continues to reshape the financial industry, AI-powered trading agents have emerged as influential tools in portfolio management and speculative trading.
#investment#artificial_intelligence
Johnson & Johnson (JNJ), a global leader in healthcare, remains a cornerstone of stability in the stock market, known for its diversified portfolio spanning pharmaceuticals, medical devices, and consumer health products. As of June 5, 2025,
Roma Green Finance Limited (ROMA), a Hong Kong-based company specializing in environmental, social, and governance (ESG) advisory services, has emerged as a compelling player in the financial markets in 2025.
Amazon (NASDAQ: AMZN) remains a cornerstone of the technology and e-commerce sectors, consistently driving innovation and market influence.
#artificial_intelligence
Overview of AAPL Stock Performance Apple Inc. (AAPL) has long been a cornerstone of the technology sector, commanding a market capitalization of approximately $3.01 trillion as of June 8, 2025.
ntroduction to Eli Lilly and Company (LLY) Eli Lilly and Company (LLY), a global pharmaceutical giant, has been a cornerstone of the healthcare sector since its founding in 1876. Headquartered in Indianapolis, Indiana, the company specializes in developing innovative treatments for diabetes, oncology, immunology, and neuroscience, with blockbuster drugs like Mounjaro and Zepbound driving significant…
Tickeron, a leader in AI-driven financial solutions, announces the launch of its latest AI trading robot designed for five high-profile stocks: Amazon.com, Inc. (AMZN), Taiwan Semiconductor Manufacturing Company, Ltd. (TSM), Walmart Inc. (WMT), Google LLC (GOOG), and Meta Platforms Inc. (META).
MicroAlgo Inc. ($MLGO), a company focused on developing advanced algorithms and AI-driven solutions, has garnered attention in the financial markets due to its volatile price movements and potential for significant upside.
The SPDR S&P 500 ETF Trust (SPY) is one of the most widely traded exchange-traded funds (ETFs) in the world, designed to track the performance of the S&P 500 Index.
Tickeron, a leader in AI-driven financial solutions, proudly announces the exceptional performance of its XAR AI Trading Agent, achieving a remarkable +62% return and an 84.16% profitable trade rate for the SPDR S&P Aerospace & Defense ETF (XAR).
#artificial_intelligence#trading
GitLab Inc. (GTLB), a leading web-based DevOps lifecycle tool, has captured significant investor attention in 2025 due to its robust performance and strategic advancements in AI integration.
The week of June 9-13, 2025, was characterized by significant market volatility driven by both positive developments in US-China trade relations and escalating geopolitical tensions in the Middle East.